Form 4 for IRMD IRADIMED CORP
Accepted 2021-12-08 00:00:00 ET · period of report 2021-12-06 · accession 0000898432-21-000757 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-12-08 | 2021-12-06 | IRMD | Susi Roger E. | Pres, CEO, COB, Dir, 10% | S - Sale | $44.37 | -10.0K | 856.0K | -1% | -$443.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-06 | S | D | 10,000 | $44.37 | 856,050 | I By Roger E. Susi Revocable Trust | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $44.00 to $45.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F3) The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. |